Open AccessA novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer
Author(s) -
Carmelo Nucera
Publication year - 2019
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.26591
Subject(s) - bromodomain , anaplastic thyroid cancer , medicine , cancer , cancer research , mek inhibitor , thyroid cancer , oncology , antagonist , targeted therapy , mapk/erk pathway , epigenetics , receptor , biology , signal transduction , biochemistry , gene